GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (OTCPK:BRAXF) » Definitions » Return-on-Tangible-Equity

BRAXF (Braxia Scientific) Return-on-Tangible-Equity : 0.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Braxia Scientific's annualized net income for the quarter that ended in Dec. 2023 was $-2.70 Mil. Braxia Scientific's average shareholder tangible equity for the quarter that ended in Dec. 2023 was $-0.58 Mil. Therefore, Braxia Scientific's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was N/A%.

The historical rank and industry rank for Braxia Scientific's Return-on-Tangible-Equity or its related term are showing as below:

BRAXF' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -8239.32   Med: -331.37   Max: -151.29
Current: -8239.32

During the past 3 years, Braxia Scientific's highest Return-on-Tangible-Equity was -151.29%. The lowest was -8,239.32%. And the median was -331.37%.

BRAXF's Return-on-Tangible-Equity is ranked worse than
99.84% of 1256 companies
in the Biotechnology industry
Industry Median: -48.155 vs BRAXF: -8239.32

Braxia Scientific Return-on-Tangible-Equity Historical Data

The historical data trend for Braxia Scientific's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific Return-on-Tangible-Equity Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
Return-on-Tangible-Equity
-1,004.15 -150.70 -308.74

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -375.78 -2,750.37 -984.11 - -

Competitive Comparison of Braxia Scientific's Return-on-Tangible-Equity

For the Biotechnology subindustry, Braxia Scientific's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Braxia Scientific's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's Return-on-Tangible-Equity falls into.



Braxia Scientific Return-on-Tangible-Equity Calculation

Braxia Scientific's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=-9.605/( (5.683+0.539 )/ 2 )
=-9.605/3.111
=-308.74 %

Braxia Scientific's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-2.704/( (-0.246+-0.92)/ 2 )
=-2.704/-0.583
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Braxia Scientific  (OTCPK:BRAXF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Braxia Scientific Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Braxia Scientific Business Description

Traded in Other Exchanges
N/A
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific Headlines

From GuruFocus